The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
TSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase
Open accessAbstract
Tuberous sclerosis complex (TSC) is an autosomal dominant disease characterized by hamartoma formation in various organs. Two genes responsible for the disease, TSC1 and TSC2, have been identified. The TSC1 and TSC2 proteins, also called hamartin and tuberin, respectively, have been shown to regulate cell growth through inhibition of the mammalian target of rapamycin pathway. TSC1 is known to stabilize TSC2 by forming a complex with TSC2, which is a GTPase-activating protein for the Rheb small GTPase. We have identified HERC1 as a TSC2-interacting protein. HERC1 is a 532-kDa protein with an E3 ubiquitin ligase homology to E6AP carboxyl terminus (HECT) domain. We observed that the interaction of TSC1 with TSC2 appears to exclude TSC2 from interacting with HERC1. Disease mutations in TSC2, which result in its destabilization, allow binding to HERC1 in the presence of TSC1. Our study reveals a potential molecular mechanism of how TSC1 stabilizes TSC2 by excluding the HERC1 ubiquitin ligase from the TSC2 complex. Furthermore, these data reveal a possible biochemical basis of how certain disease mutations inactivate TSC2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TSC1 is an HSP-90 co-chaperone and protects TSC2 from HERC1-mediated ubiquitination and degradation (29).”
From Enhanced mTORC1 signaling and Protein Synthesis in Parkinson’s Disease Pathogenesis Disease Pathogenesis (2022) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Self-citationFingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,264
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Zhang, Y., Gao, X., Saucedo, L. J., Ru, B., Edgar, B. A., & Pan, D. (2003) · Nature Cell Biology · doi:10.1038/ncb999 · Cited by 924
Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827
Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1
Bischoff, F. R., & Ponstingl, H. (1991) · Nature · doi:10.1038/354080a0 · Cited by 711
Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling
Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R. S. W., Ru, B., & Pan, D. (2002) · Nature Cell Biology · doi:10.1038/ncb847 · Cited by 689
Kwiatkowski, D. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.525 · Cited by 674
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases
Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K., & Reimann, J. D. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01834-1 · Cited by 635
Research works printed but not linked: 1
- Zhang, 2003, J. Clin. Invest., 112, 1223, 10.1172/JCI200317222 · DOI
Cited by
Sorted by citations
Items 101–200 of 235
Gai, Z., Chu, W., Deng, W., Li, W., Li, H. L., He, A., Nellist, M. D., & Wu, G. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw001 · Cited by 41
Hwang, S., Lee, J., Yang, J.-E., Lim, C., Lee, J., Lee, Y., Lee, K., & Kaang, B. (2016) · Molecular Brain · doi:10.1186/s13041-016-0222-6 · Cited by 40
Aggarwal, S., Bhowmik, A. D., Ramprasad, V. L., Murugan, S., & Dalal, A. B. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37654 · Cited by 38
PEX5 regulates autophagy via the mTORC1-TFEB axis during starvation
Eun, S. Y., Lee, J. N., Nam, I.-K., Liu, Z., So, H., Choe, S., & Park, R. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-017-0007-8 · Cited by 38
Zhao, Z., Xu, Q., Wei, R., Wang, W., Ding, D., Yang, Y., Yao, J., Zhang, L., Hu, Y., Wei, G., et al. (2021) · Genome Research · doi:10.1101/gr.271627.120 · Cited by 40
Qin, J., Wang, Z., Hoogeveen-Westerveld, M., Shen, G., Gong, W., Nellist, M., & Xu, W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701870 · Cited by 37
An Autoinhibited Noncanonical Mechanism of GTP Hydrolysis by Rheb Maintains mTORC1 Homeostasis
Mazhab-Jafari, M. T., Marshall, C. B., Ishiyama, N., Ho, J., Di Palma, V., Stambolic, V., & Ikura, M. (2012) · Structure · doi:10.1016/j.str.2012.06.013 · Cited by 37
The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation
Schneider, T., Martinez-Martinez, A., Cubillos‐Rojas, M., Bartrons, R., Ventura, F., & Rosa, J. L. (2018) · Oncotarget · doi:10.18632/oncotarget.25847 · Cited by 37
Self-citationAberrant expression of TSC2 gene in the newly diagnosed acute leukemia
Xu, Z., Wang, M., Wang, L., Wang, Y., Zhao, X., Rao, Q., & Wang, J. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.01.041 · Cited by 38
Identification of TBC7 having TBC domain as a novel binding protein to TSC1–TSC2 complex
Nakashima, A., Yoshino, K., Miyamoto, T., Eguchi, S., Oshiro, N., Kikkawa, U., & Yonezawa, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.011 · Cited by 36
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1
Lin, W., Wan, X., Sun, A., Zhou, M., Chen, X., Li, Y., Wang, Z., Huang, H., Li, H., Chen, X., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.10.009 · Cited by 36
Self-citationAmino acid and small GTPase regulation of mTORC1
Nguyen, T. P., Frank, A. R., & Jewell, J. L. (2017) · Cellular Logistics · doi:10.1080/21592799.2017.1378794 · Cited by 37
Hochrainer, K., Kroismayr, R., Baranyi, U., Binder, B. R., & Lipp, J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8148-5 · Cited by 34
Shen, Y., Goncharov, D. A., Pena, A. Z., Baust, J., Barragan, A. C., Ray, A., Rode, A., Bachman, T. N., Chang, B., Jiang, L., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abn2743 · Cited by 34
Ko, C., Zhang, L., Jie, Z., Zhu, L., Zhou, X., Xie, X., Gao, T., Yang, J., Cheng, X., & Sun, S. (2020) · The EMBO Journal · doi:10.15252/embj.2020104532 · Cited by 34
Architecture of the Tuberous Sclerosis Protein Complex
Ramlaul, K., Fu, W., Li, H., de Martin Garrido, N., He, L., Trivedi, M., Cui, W., Aylett, C. H. S., & Wu, G. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.166743 · Cited by 34
Rheb regulates nuclear mTORC1 activity independent of farnesylation
Zhong, Y., Zhou, X., Guan, K., & Zhang, J. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.02.006 · Cited by 34
Self-citationFunctional specificity of Akt isoforms in cancer progression
Fortier, A.-M., Asselin, É., & Cadrin, M. (2011) · BioMolecular Concepts · doi:10.1515/bmc.2011.003 · Cited by 28
The HERC proteins and the nervous system
Pérez-Villegas, E. M., Ruiz, R., Bachiller, S., Ventura, F., Armengol, J. A., & Rosa, J. L. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.11.017 · Cited by 32
Self-citationHuang, L., Wang, Z.-B., Jiang, Z.-Z., Hu, M., Lin, F., Zhang, Q.-H., Luo, Y.-B., Hou, Y., Zhao, Y. X., Fan, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054052 · Cited by 28
Sun, W., Zhu, Y. J., Wang, Z., Zhong, Q., Gao, F., Lou, J., Gong, W., & Xu, W. (2013) · Nature Communications · doi:10.1038/ncomms3135 · Cited by 27
Pan, H., Zhong, X., & Lee, S. (2016) · BMC Biochemistry · doi:10.1186/s12858-016-0069-6 · Cited by 27
Mohan, N., Shen, Y., Dokmanovic, M., Endo, Y., Hirsch, D. S., & Wu, W. J. (2016) · Oncotarget · doi:10.18632/oncotarget.10469 · Cited by 28
The role of TSC2 in breast cancer: a literature review
Zhu, Q., He, Z.-M., Cao, W., & Li, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1188371 · Cited by 26
Jin, F., Jiang, K., Ji, S., Wang, L., Ni, Z., Huang, F., Li, C., Chen, R., Zhang, H., Hu, Z., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw397 · Cited by 26
TSC1/TSC2 inactivation inhibits AKT through mTORC1‐dependent up‐regulation of STAT3‐PTEN cascade
Zha, X., Hu, Z., He, S., Wang, F., Shen, H., & Zhang, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.006 · Cited by 25
Genetic Evaluation of Common Neurocutaneous Syndromes
Gürsoy, S., & Erçal, D. (2018) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2018.08.006 · Cited by 24
Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer
Qin, X., Wang, X., Liu, F., Morris, L. E., Wang, X., Jiang, B., & Zhang, Y. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.013 · Cited by 23
Protein Phosphorylation as a Key Mechanism of mTORC1/2 Signaling Pathways
Tchevkina, E. M., & Komelkov, A. V. (2012) · InTech eBooks · doi:10.5772/48274 · Cited by 26
Ubiquitination and E3 Ubiquitin Ligases in Rare Neurological Diseases with Comorbid Epilepsy
Zhu, J., & Tsai, N. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.12.030 · Cited by 24
Tsc1 regulates tight junction independent of mTORC1
Lai, M., Zou, W., Han, Z., Zhou, L., Qiu, Z., Chen, J., Zhang, S., Lai, P., Li, K., Zhang, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020891118 · Cited by 22
Constitutive and induced functions of the p53 gene
Zheltukhin, A. O., & Chumakov, P. M. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910130110 · Cited by 23
The role of TSC1 and TSC2 proteins in neuronal axons
Karalis, V., Wood, D., Teaney, N. A., & Sahin, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02402-7 · Cited by 21
España, J., Tuveson, D. A., Adams, D. J., & Matakidou, A. (2015) · Scientific Reports · doi:10.1038/srep11061 · Cited by 21
Kladney, R. D., Cardiff, R. D., Kwiatkowski, D. J., Chiang, G. G., Weber, J. D., Arbeit, J. M., & Lu, Z. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1646 · Cited by 21
Krishna, S., Yang, J., Wang, H., Qiu, Y., & Zhong, X. (2014) · Infection and Immunity · doi:10.1128/iai.01816-14 · Cited by 20
The HERC1 ubiquitin ligase regulates presynaptic membrane dynamics of central synapses
Montes-Fernández, M. A., Pérez-Villegas, E. M., García-Gonzalo, F. R., Pedrazza, L., Rosa, J. L., de Toledo, G. Á., & Armengol, J. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-68970-8 · Cited by 20
Self-citationTSC2 regulates tumor susceptibility to TRAIL‐mediated T‐cell killing by orchestrating mTOR signaling
Lin, C., Traets, J. J. H., Vredevoogd, D. W., Visser, N. L., & Peeper, D. S. (2023) · The EMBO Journal · doi:10.15252/embj.2022111614 · Cited by 19
HERC1 Ubiquitin Ligase Is Required for Normal Axonal Myelination in the Peripheral Nervous System
Bachiller, S., Roca-Ceballos, M. A., García-Domínguez, I., Pérez-Villegas, E. M., Martos-Carmona, D., Pérez‐Castro, M. A., Real, L. M., Rosa, J. L., Tabares, L., Venero, J. L., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1021-0 · Cited by 19
Self-citationSegreto, R., Bazafkan, H., Millinger, J., Schenk, M., Atanasova, L., Doppler, M., Bueschl, C., Boeckstaens, M., Diaz, S. S., Schreiner, U., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0262180 · Cited by 17
Wong, H. T., McCartney, D. L., Lewis, J. C., Sampson, J. R., Howe, C. J., & de Vries, P. J. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103154 · Cited by 19
microRNA 92b-3p regulates primordial follicle assembly by targeting TSC1 in neonatal mouse ovaries
Li, T., Liu, X., Gong, X., Qiukai, E., Zhang, X., & Zhang, X. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1593648 · Cited by 18
Hari, A. S., Banerji, R., Liang, L., Fulton, R. E., Huynh, C. Q., Fabisiak, T., McElroy, P. B., Roede, J. R., & Patel, M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102895 · Cited by 17
Analysis of TSC1 mutation spectrum in mucosal melanoma
Ma, M., Dai, J., Xu, T., Yu, S., Yu, H., Tang, H., Yan, J., Wu, X., Yu, J., Chi, Z., et al. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2550-z · Cited by 17
Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis
Sager, R., Woodford, M. R., Shapiro, O., Mollapour, M., & Bratslavsky, G. (2018) · Oncotarget · doi:10.18632/oncotarget.25164 · Cited by 17
Amino acid sensory complex proteins in mTORC1 and macroautophagy regulation
Seibert, M., Kurrle, N., Schnütgen, F., & Serve, H. L. (2021) · Matrix Biology · doi:10.1016/j.matbio.2021.01.001 · Cited by 18
Molecular aspects of follicular development
Huang, Z., & Wells, D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921896.013 · Cited by 15
Ohsawa, M., Kobayashi, T., Okura, H., Igarashi, T., Mizuguchi, M., & Hino, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054503 · Cited by 15
Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Pignatelli, M., Feligioni, M., Piccinin, S., Molinaro, G., Nicoletti, F., & Nisticò, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360008 · Cited by 14
Piha-Paul, S. A., Hong, D. S., & Kurzrock, R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5928 · Cited by 14
Bah, I., Fahiminiya, S., Bégin, L. R., Hamel, N., D’Agostino, D., Tanguay, S., & Foulkes, W. D. (2018) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.104 · Cited by 13
The evolution and diversification of the Hsp90 co-chaperone system
Engler, S., & Büchner, J. (2025) · Biological Chemistry · doi:10.1515/hsz-2025-0112 · Cited by 12
Lugnier, C., Majores, M., Fassunke, J., Pernhorst, K., Niehusmann, P., Simon, M., Nellist, M. D., Schoch, S., & Becker, A. J. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b9a699 · Cited by 12
Woodford, M. R., Backe, S. J., Sager, R., Bourboulia, D., Bratslavsky, G., & Mollapour, M. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.03.016 · Cited by 13
Winden, K. D., Bebin, E. M., Jeste, S., Krueger, D. A., Paul, E., & Sahin, M. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00688-9 · Cited by 12
Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis
Wang, C., Stapleton, D. S., Schueler, K. L., Rabaglia, M. E., Oler, A. T., Keller, M. P., Kendziorski, C. M., Broman, K. W., Yandell, B. S., Schadt, E. E., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m025239 · Cited by 11
Molecular chaperones: Guardians of tumor suppressor stability and function
Heritz, J. A., Backe, S. J., & Mollapour, M. (2024) · Oncotarget · doi:10.18632/oncotarget.28653 · Cited by 11
Biological function derived from predicted structures in CASP11
Huwe, P. J., Xu, Q., Shapovalov, M. V., Modi, V., Andrake, M., & Dunbrack, R. L. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24997 · Cited by 10
Mrozek, E. M., Bajaj, V., Guo, Y., Malinowska, I. A., Zhang, J., & Kwiatkowski, D. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248380 · Cited by 10
Qin, Z., Zheng, H., Zhou, L., Ou, Y., Huang, B., Yan, B., Qin, Z., Yang, C., Su, Y., Bai, X., et al. (2016) · Scientific Reports · doi:10.1038/srep19587 · Cited by 10
Schwarz, J. M., Pedrazza, L., Stenzel, W., Rosa, J. L., Schuelke, M., & Straussberg, R. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.08.008 · Cited by 12
Self-citationHamartin: An Endogenous Neuroprotective Molecule Induced by Hypoxic Preconditioning
Li, S., Ren, C., Stone, C., Chandra, A., Xu, J., Li, N., Han, C., Ding, Y., Ji, X., & Shao, G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.582368 · Cited by 9
Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer
Backe, S. J., Sager, R., Meluni, K. A., Woodford, M. R., Bourboulia, D., & Mollapour, M. (2022) · Biomolecules · doi:10.3390/biom12070928 · Cited by 9
Ferreri, A., Lang, V., Kaufmann, R., & Buerger, C. (2022) · Cells · doi:10.3390/cells11182847 · Cited by 9
Tuberous sclerosis complex: genetic basis and management strategies
Crino, P. B., & Tsai (2012) · Advances in Genomics and Genetics · doi:10.2147/agg.s19837 · Cited by 9
Impact of Co-chaperones and Posttranslational Modifications Toward Hsp90 Drug Sensitivity
Backe, S. J., Woodford, M. R., Ahanin, E. F., Sager, R., Bourboulia, D., & Mollapour, M. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-14740-1_11 · Cited by 8
Phosphorylated hamartin–Hsp70 complex regulates apoptosis via mitochondrial localization
Inoue, H., Uyama, T., Suzuki, T., Kazami, M., Hino, O., Kobayashi, T., Kobayashi, K., Tadokoro, T., & Yamamoto, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.054 · Cited by 8
Research Translation and Personalized Medicine
Brugarolas, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_8 · Cited by 7
(2010) · The Enzymes · doi:10.1016/s1874-6047(10)28002-2 · Cited by 8
Bąbol‐Pokora, K., Bielska, M., Bobeff, K. Ł., Jatczak‐Pawlik, I., Borkowska, J., Kotulska, K., Jóźwiak, S., Mlynarski, W. M., & Trelińska, J. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104309 · Cited by 7
The dual role of the TSC complex in cancer
Hartung, J., Müller, C., & Calkhoven, C. F. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.10.009 · Cited by 8
Sakamoto, H., Yamasaki, T., Sumiyoshi, T., Utsunomiya, N., Takeda, M., Kamba, T., Nakamura, E., & Ogawa, O. (2018) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2018-205211 · Cited by 6
Translational Medicine Strategies in Drug Development for Neurodevelopmental Disorders
Srivastava, S., Şahin, M., & Prock, L. A. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00022-9 · Cited by 6
Importance of tuberin in carcinogenesis
Jin, M., An, Q., & Wang, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6490 · Cited by 6
Glushkova, M., Bojinova, V., Koleva, M., Dimova, P. S., Bojidarova, M., Litvinenko, I., Тодоров, Т., Iluca, E., Calusaru, C., Neagu, E., et al. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0927-7 · Cited by 6
Guo, A., Lun, P., Chen, J., Li, Q., Chang, K., Li, T., Pan, D., Zhang, J., Zhou, J., Wang, K., et al. (2022) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000321 · Cited by 6
Nandi, P., Jang, C. E., Biggar, K. K., Halari, C. D., Jansson, T., & Gupta, M. B. (2021) · Biomolecules · doi:10.3390/biom11091382 · Cited by 5
New insights into tuberous sclerosis complex: from structure to pathogenesis
Chen, C.-S., & Aylett, C. H. S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1595867 · Cited by 8
TSC2 loss in neural progenitor cells suppresses mRNA translation of neurodevelopmental genes
Martin, P., Szkop, K. J., Robert, F., Bhattacharyya, S., Beauchamp, R. L., Brenner, J., Redmond, N. E., Huang, S., Erdin, S., Larsson, O. S., et al. (2025) · Brain · doi:10.1093/brain/awaf081 · Cited by 6
Li, H., Dairo, O., Lotan, T. L., Argani, P., & Matoso, A. (2025) · Human Pathology · doi:10.1016/j.humpath.2025.105764 · Cited by 4
Li, B., Wang, C., Yu, A., Chen, Y., & Zuo, Z. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.05.002 · Cited by 4
Sestrins Link Tumor Suppressors with the AMPK-TOR Signaling Network
Andrei, V. (2012) · InTech eBooks · doi:10.5772/48554 · Cited by 4
Aberrant mTOR/autophagy/Nurr1 signaling is critical for TSC-associated tumor development
Wang, Y., Li, C., Zhang, Y., Zha, X., Zhang, H., Hu, Z., & Wu, C. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0017 · Cited by 4
Genotype–phenotype correlations in tuberous sclerosis: Who and how to treat
Goh, S., & Weiss, W. A. (2006) · Annals of Neurology · doi:10.1002/ana.20917 · Cited by 4
Ganesan, I. P., & Kiyokawa, H. (2025) · Cancers · doi:10.3390/cancers17040626 · Cited by 3
Ojha, S. K., Kartawy, M., Hamoudi, W., Tripathi, M. K., Aran, A. A., & Amal, H. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03514-6 · Cited by 4
HERC1 polymorphisms: population‐specific variations in haplotype composition
Yuasa, I., Umetsu, K., Nishimukai, H., Fukumori, Y., Harihara, S., Saitou, N., Jin, F., Chattopadhyay, P. K., Henke, L., & Henke, J. (2009) · Cell Biochemistry and Function · doi:10.1002/cbf.1582 · Cited by 3
Hereditary Renal Cell Carcinoma
Baba, M., Schmidt, L. S., & Linehan, W. M. (2017) · Springer eBooks · doi:10.1007/978-4-431-55531-5_2 · Cited by 4
Biology of Human Liver Stem Cells
Strain, A. J., Nijjar, S. S., & Crosby, H. A. (2004) · doi:10.1007/978-1-59259-411-5_35 · Cited by 3
The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia
Jankovic, M., Poon, W. W. L., González‐Losada, C., Galicia-Vázquez, G., Sharif-Askari, B., Ding, Y., Craplet-Desombre, C., Ilié, A., Shi, J., Wang, Y., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023011540 · Cited by 2
Pérez‐Castro, M. A., Hernández-Rasco, F., Alonso-Bellido, I. M., Letrán-Sánchez, M. D. L. S., Pérez-Villegas, E. M., Vitallé, J., Real, L. M., Ruíz-Mateos, E., Venero, J. L., Tabares, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020793 · Cited by 2
Structure and Function of the mTOR Activator Rheb
Marshall, C. B., Mazhab‐Jafari, M. T., Stambolic, V., & Ikura, M. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1806-1_13 · Cited by 2
Mutational and functional study of Tuberous Sclerosis Complex 1 and 2 genes (TSC1 and TSC2)
de Almeida, L. G. D. (2019) · doi:10.11606/t.41.2019.tde-27082019-100610 · Cited by 2
E3 ubiquitin ligases and cerebral cortex development in health and disease
Lambert, N., Moïse, M., & Nguyen, L. (2022) · Developmental Neurobiology · doi:10.1002/dneu.22877 · Cited by 1
Cerebellar Biochemistry/Pharmacology
Seki, T. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_3 · Cited by 1
Hu, S., Wang, Y., Wu, T. Y., Luo, H., Chen, J., Wang, Y., Li, C., Yin, S., Guo, Z., Zhu, Y., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202500019r · Cited by 1
YIF1A activates mTORC1 signaling to promote cellular senescence
Zhang, X., Liu, L., Shang, M., Hu, B., Zhu, S., Wang, X., Jieying, L., Han, Y., Wei, X., Cao, Q., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09034-z · Cited by 1
Regulation of Quiescence and Activation of Oocyte Growth in Primordial Follicles
Adhikari, D., & Liu, K. (2012) · Springer eBooks · doi:10.1007/978-0-85729-826-3_4 · Cited by 1
Thinking Inside the Box: Drosophila F-Box Protein Models of Human Disease
Merzetti, E. M., Connors, C. B., & Staveley, B. E. (2013) · Cited by 1
Srivastava, S., & Şahin, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814409-1.00001-x · Cited by 1
Metadata
- Authors
- Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F. R., Rosa, J. L., & Guan, K.-L.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Guan, Kun-Liang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 281
- Issue
- 13
- Pages
- 8313-8316
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984412362
- Cited by
- 234
- References
- 30
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 10 · 2021: 13 · 2020: 11 · 2019: 6 · 2018: 11 · 2017: 14 · 2016: 18 · 2015: 7 · 2014: 11 · 2013: 12 · 2012: 21
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Funders
- National Institute on Aging (T32-AG00114-18, T32AG000114)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124709)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- tuberous sclerosis complex, TSC1, TSC2, hamartin, tuberin, HERC1, E3 ubiquitin ligase, protein-protein interaction, protein stabilization, HECT domain, pathogenic variants, mTOR signaling, hamartoma
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Amino Acid Sequence, Animals, Brain Chemistry, Cell Extracts, Cell Line, Cycloheximide, Humans, Ligases, Precipitin Tests, Protein Synthesis Inhibitors, Blotting, Western, Silver Staining, Gene Deletion, Protein Structure, Tertiary, Guanine Nucleotide Exchange Factors, Protein Subunits, Tumor Suppressor Proteins, Ubiquitin, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review